TORL BioTherapeutics, LLC

📍 Culver City, United States🗓 Founded 2018👥 26 employees💰 Last funded Apr 2023
Biotechnology Research🌐 torlbio.com
Website LinkedIn
A clinical-stage biopharmaceutical company advancing the development of new biologics for cancer treatment. TORL-Bio was founded in 2018 and is focused on the development of novel antibody-based therapeutics for cancer patients. TORL has currently 3 therapeutics in Ph1 clinical trials in indications such as NSCLC, gastric, pancreatic and ovarian cancers
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in TORL BioTherapeutics, LLC?
TORL BioTherapeutics, LLC has 1 investors on record on gritt.io, 1 mid-stage.
When did TORL BioTherapeutics, LLC last raise funding?
The most recent investment in TORL BioTherapeutics, LLC recorded on gritt.io was in April 2023.
When was TORL BioTherapeutics, LLC founded?
TORL BioTherapeutics, LLC was founded in 2018.
What industry is TORL BioTherapeutics, LLC in?
TORL BioTherapeutics, LLC operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is TORL BioTherapeutics, LLC based?
TORL BioTherapeutics, LLC is headquartered in Culver City, United States.